P63S (p.Pro63Ser) variant of DMD (Dystrophin)

P63S (p.Pro63Ser) in DMD (Dystrophin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.51 / 1. The record also includes population frequency data, published literature, and structural context.

P63S (p.Pro63Ser) variant details